Common Stock (Details Narrative) |
1 Months Ended | 3 Months Ended | 6 Months Ended | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jan. 07, 2026
USD ($)
$ / shares
shares
|
Nov. 07, 2025
USD ($)
$ / shares
shares
|
Oct. 14, 2025
USD ($)
$ / shares
shares
|
Oct. 10, 2025
USD ($)
$ / shares
shares
|
Aug. 04, 2025
USD ($)
|
May 15, 2025
USD ($)
shares
|
Sep. 18, 2025
USD ($)
$ / shares
shares
|
Sep. 18, 2025 |
Apr. 22, 2025
USD ($)
shares
|
Mar. 24, 2025 |
Jun. 30, 2026
USD ($)
integer
$ / shares
shares
|
Jun. 30, 2025
USD ($)
|
Jun. 30, 2026
USD ($)
integer
$ / shares
shares
|
Jun. 30, 2025
USD ($)
|
Jun. 07, 2026
$ / shares
shares
|
Dec. 31, 2025
$ / shares
shares
|
|
| Common stock, shares issued | shares | 12,044,339 | 12,044,339 | 6,288,988 | |||||||||||||
| Common Stock, shares, outstanding | shares | 12,044,339 | 12,044,339 | 6,288,988 | |||||||||||||
| Sales commissions and fees | $ 8,313,019 | |||||||||||||||
| Sale of shares of common stock, shares | shares | 1,684,657 | |||||||||||||||
| Common stock price per share | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | |||||||||||||
| Common stock, shares authorized | shares | 325,000,000 | 325,000,000 | 325,000,000 | |||||||||||||
| Repayment obligations | $ 26,963 | $ 24,219 | ||||||||||||||
| Loss on extinguishment of debt | $ (595,500) | $ 0 | (1,583,434) | $ 0 | ||||||||||||
| Shares Issued in Repayment of Convertible Notes | ||||||||||||||||
| Repayment obligations | $ 3,700,000 | |||||||||||||||
| Aggregate share | shares | 1,302,343 | 1,302,343 | ||||||||||||||
| Aggregate fair value | $ 4,200,000 | |||||||||||||||
| Loss on extinguishment of debt | $ 1,600,000 | |||||||||||||||
| Directors And Officers [Member] | ||||||||||||||||
| Purchased shares of common stock | shares | 254,229 | |||||||||||||||
| Net proceeds | $ 5,400,000 | |||||||||||||||
| Securities Purchase Agreement [Member] | ||||||||||||||||
| Agreement of several purchases offering, description | (i) 156,250 shares of the Company’s common stock to certain of its directors and executive officers (collectively, the “Insider Purchasers”) at an offering price of $0.64 per share (the “August 2025 Insider Shares”), and (ii) 1,734,375 shares of common stock (the “August 2025 Warrant Investor Shares” and, together with the August 2025 Insider Shares, the “August 2025 Shares”), together with common stock purchase warrants to purchase up to 1,734,735 shares of common stock (the “August 2025 Warrants”), at a combined offering price of $0.64 per August 2025 Warrant Investor Share and accompanying August 2025 Warrant, to certain other existing stockholders of the Company. Each August 2025 Warrant has an exercise price per share of $0.768, and is exercisable on or after August 4, 2025 through and until August 4, 2030. The Insider Purchasers did not receive any August 2025 Warrants in the offering | (i) 118,182 shares of the Company’s common stock to certain of its directors and executive officers, and certain of its existing stockholders (collectively, the “Insiders”) at an offering price of $11.0 per share (the “Insider Shares”), and (ii) 86,954 shares of common stock (the “March 2025 Warrant Investor Shares” and, together with the Insider Shares, the “March 2025 Shares”), together with common stock purchase warrants to purchase up to 86,954 shares of common stock (the “March 2025 Warrants”), at a combined offering price of $11.0 per March 2025 Warrant Investor Share and accompanying March 2025 Warrant, to certain other existing stockholders of the Company and new investors (collectively, the “Warrant Investors”). Each March 2025 Warrant has an exercise price per share of $13.20, and is exercisable on or after March 26, 2025 through and until March 26, 2030. The Insiders did not receive any March 2025 Warrants in the offering. The net proceeds received by the Company for the issuance and sale of the March 2025 Shares and the March 2025 Warrants were $2.3 million, before deducting offering expenses of $0.1 million paid by the Company | ||||||||||||||
| Proceed from issuance and sale of shares and warrants | $ 1,210,000 | |||||||||||||||
| Offering expenses | $ 100,000 | |||||||||||||||
| Securities Purchase Agreement [Member] | Lind Global Asset Management XII LLC [Member] | ||||||||||||||||
| Warrants issued to purchase common shares | shares | 350,018 | 651,042 | ||||||||||||||
| Common stock per share | $ / shares | $ 11.428 | |||||||||||||||
| Funding received | $ 2,000,000 | |||||||||||||||
| Principal amount | 2,400,000 | $ 7,500,000 | ||||||||||||||
| Commitment fee | $ 70,000 | |||||||||||||||
| 2025 ATM Sales Agreement [Member] | ||||||||||||||||
| Common stock aggregate offering price amount | $ 7,500,000 | |||||||||||||||
| Description of aggregate offering price | sold under the 2025 ATM Sales Agreement from $7.5 million to $30.0 million | |||||||||||||||
| Sales commissions and fees | $ 1,212,344 | |||||||||||||||
| Sales commissions and fees, shares | shares | 754,798 | |||||||||||||||
| Sale of shares of common stock | $ 6,622,685 | |||||||||||||||
| Sale of shares of common stock, shares | shares | 1,466,452 | |||||||||||||||
| 2026 Lind Note [Member] | ||||||||||||||||
| Number of installments | integer | 18 | 18 | ||||||||||||||
| Conversion price | $ / shares | $ 11.42 | $ 11.42 | ||||||||||||||
| Repayment obligations | $ 250,000 | |||||||||||||||
| Monthly installments | $ 133,333 | |||||||||||||||
| Installment description | While the 2026 Lind Note is outstanding, Lind may elect with respect to no more than two monthly payments to increase the amount of such monthly payment up to $1,000,000 upon notice to the Company. The monthly payments due under the 2026 Lind Note may be made by the issuance of common stock valued at the Repayment Share Price (as defined below), cash in an amount equal to 1.05 times the required payment amount, or a combination of cash and shares of the Company’s common stock. The “Repayment Share Price” is defined in the 2026 Lind Note as 90% of the average of the five lowest daily volume weighted average prices of one share of the Company’s common stock during the 20 trading days prior to the payment date | |||||||||||||||
| Aggregate share | shares | 210,011 | 210,011 | 1,480,000 | |||||||||||||
| Repayment conversion description | ownership limitation equal to 4.99% of the Company’s outstanding shares of common stock; provided, that if Lind and its affiliates beneficially own in excess of 4.99% of the Company’s outstanding shares of common stock, then such limitation shall automatically increase to 9.99% so long as Lind and its affiliates own in excess of 4.99% of such common stock (and shall, for the avoidance of doubt, automatically decrease to 4.99% upon Lind and its affiliates ceasing to own in excess of 4.99% of such common stock) | |||||||||||||||
| Warrants exercise price | $ / shares | $ 1.55 | $ 1.55 | $ 2.01 | |||||||||||||
| Placement fees | $ 4,100,000 | |||||||||||||||
| Warrants fully exercised on cash basis | $ 2,300,000 | $ 2,300,000 | ||||||||||||||
| June 2026 Confidentially Marketed Public Offering [Member] | ||||||||||||||||
| Aggregate share | shares | 2,960,000 | 2,960,000 | ||||||||||||||
| Offering price | $ / shares | $ 1.55 | $ 1.55 | ||||||||||||||
| Warrants exercise price | $ / shares | $ 1.55 | $ 1.55 | ||||||||||||||
| September 2025 Private Placement [Member] | ||||||||||||||||
| Warrants expiry date | September 18, 2030 | |||||||||||||||
| Number of warrants issued | shares | 483,870 | |||||||||||||||
| Proceed from issuance and sale of shares and warrants | $ 300,000 | |||||||||||||||
| Common stock issued for cash, net of issuance costs, shares | shares | 483,870 | |||||||||||||||
| Offering expenses | $ 20,000.00 | |||||||||||||||
| Combined offering price | $ / shares | $ 0.62 | |||||||||||||||
| Exercise price per share | $ / shares | $ 0.68 | |||||||||||||||
| Underwriting Agreement [Member] | ||||||||||||||||
| Number of warrants issued | shares | 83,580 | |||||||||||||||
| Purchased shares of common stock | shares | 808,500 | |||||||||||||||
| Net proceeds | $ 582,426 | |||||||||||||||
| Initial shares of common stock | shares | 11,550,000 | |||||||||||||||
| Pre-funded warrants | shares | 1,732,500 | |||||||||||||||
| Purchase option warrants | shares | 1,732,500 | |||||||||||||||
| Purchase option Shares | shares | 1,194,000 | |||||||||||||||
| Purchase price per share | $ / shares | $ 0.51 | $ 0.63 | $ 0.01 | |||||||||||||
| Purchase to additional shares of options | shares | 1,194,000 | |||||||||||||||
| Exercise prices | $ / shares | $ 0.01 | $ 0.60 | ||||||||||||||
| Purchase to additional shares of common stock | shares | 1,732,500 | |||||||||||||||
| Issued warrants to purchase shares of common stock | shares | 11,550,000 | |||||||||||||||
| Common stock offering price | $ / shares | $ 0.52 | |||||||||||||||
| Fees and expenses | $ 100,000 | |||||||||||||||